Emerge Diagnostics' Series A - II Round

Emerge Diagnostics raised a round of funding on June 23, 2016.

Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between ac…

Articles about Emerge Diagnostics' Series A - II Round: